Mativ (MATV) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
Annual Meeting scheduled for April 30, 2025, to be held virtually, with voting on key proposals including director election, auditor ratification, executive compensation, and an amendment to the equity plan.
Shareholders of record as of March 10, 2025, are eligible to vote; a majority of outstanding shares is required for quorum.
The Board recommends voting FOR all proposals on the agenda.
Voting matters and shareholder proposals
Election of Kimberly E. Ritrievi, ScD as Class III director for a term expiring at the 2028 Annual Meeting.
Ratification of Deloitte & Touche LLP as independent registered public accounting firm for 2025.
Non-binding advisory vote to approve executive compensation (say-on-pay).
Approval of an amendment to the 2024 Equity and Incentive Plan, increasing available shares by 2,300,000.
Procedures for shareholder proposals and director nominations for the 2026 Annual Meeting are outlined.
Board of directors and corporate governance
Board consists of five directors post-meeting, with four of five being independent.
Board divided into three classes; directors not eligible for re-election after age 72 unless an exception is made.
Board diversity includes gender and racial representation; skills matrix covers strategic, financial, legal, and ESG expertise.
Standing committees: Audit, Compensation, and Nominating & Governance, all composed of independent directors.
Annual board and committee evaluations, director training, and overboarding policy in place.
No stockholder rights plan; majority vote resignation policy for directors.
Latest events from Mativ
- Operational transformation and targeted investments drive growth and margin expansion.MATV
Investor presentation25 Mar 2026 - Annual meeting to vote on directors, auditor, compensation, and equity plan amendment.MATV
Proxy Filing17 Mar 2026 - Proxy covers director elections, auditor ratification, compensation, and equity plan amendment.MATV
Proxy Filing17 Mar 2026 - Record free cash flow and EBITDA gains achieved despite market headwinds and goodwill impairment.MATV
Q4 202519 Feb 2026 - Adjusted EBITDA rose 13% year-over-year, with margin and cash flow improvements in Q2 2024.MATV
Q2 20242 Feb 2026 - Adjusted EBITDA up 10% on flat sales; SAS growth offsets FAM headwinds amid restructuring.MATV
Q3 202416 Jan 2026 - SaaS/SAS growth and cost actions offset FAM headwinds, supporting 2025 profit improvement.MATV
Q4 202423 Dec 2025 - All proposals passed, including director election and equity plan amendment; no questions raised.MATV
AGM 202523 Dec 2025 - Annual meeting to vote on director election, auditor ratification, pay, and equity plan.MATV
Proxy Filing2 Dec 2025